BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 31559708)

  • 1. Does the Time Interval from Biopsy to Radical Prostatectomy Affect the Postoperative Oncologic Outcomes in Korean Men?
    Kim SJ; Ryu JH; Yang SO; Lee JK; Jung TY; Kim YB
    J Korean Med Sci; 2019 Sep; 34(37):e234. PubMed ID: 31559708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New Prostate Cancer Grading System Predicts Long-term Survival Following Surgery for Gleason Score 8-10 Prostate Cancer.
    Ham WS; Chalfin HJ; Feng Z; Trock BJ; Epstein JI; Cheung C; Humphreys E; Partin AW; Han M
    Eur Urol; 2017 Jun; 71(6):907-912. PubMed ID: 27876305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic impact of downgrading and upgrading from biopsy to radical prostatectomy among men with Gleason score 7 prostate cancer.
    Jang WS; Koh DH; Kim J; Lee JS; Chung DY; Ham WS; Rha KH; Choi YD
    Prostate; 2019 Dec; 79(16):1805-1810. PubMed ID: 31483062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Prostate-specific Antigen Persistence After Radical Prostatectomy for the Prediction of Clinical Progression and Cancer-specific Mortality in Node-positive Prostate Cancer Patients.
    Bianchi L; Nini A; Bianchi M; Gandaglia G; Fossati N; Suardi N; Moschini M; Dell'Oglio P; Schiavina R; Montorsi F; Briganti A
    Eur Urol; 2016 Jun; 69(6):1142-8. PubMed ID: 26749093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative Statin Use at the Time of Radical Prostatectomy Is Not Associated With Biochemical Recurrence or Pathologic Upgrading.
    Lyon TD; Turner RM; Yabes JG; Woldemichael E; Davies BJ; Jacobs BL; Nelson JB
    Urology; 2016 Nov; 97():153-159. PubMed ID: 27516122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Impact of Prostate Cancer Upgrading and Upstaging on Biochemical Recurrence and Cancer-Specific Survival.
    Bakavičius A; Drevinskaitė M; Daniūnaitė K; Barisienė M; Jarmalaitė S; Jankevičius F
    Medicina (Kaunas); 2020 Feb; 56(2):. PubMed ID: 32033148
    [No Abstract]   [Full Text] [Related]  

  • 7. Postoperative upgrading of prostate cancer in men ≥75 years: a propensity score-matched analysis.
    Herlemann A; Buchner A; Kretschmer A; Apfelbeck M; Stief CG; Gratzke C; Tritschler S
    World J Urol; 2017 Oct; 35(10):1517-1524. PubMed ID: 28493044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary Gleason grade 4 at the positive margin is associated with metastasis and death among patients with Gleason 7 prostate cancer undergoing radical prostatectomy.
    Viers BR; Sukov WR; Gettman MT; Rangel LJ; Bergstralh EJ; Frank I; Tollefson MK; Thompson RH; Boorjian SA; Karnes RJ
    Eur Urol; 2014 Dec; 66(6):1116-24. PubMed ID: 25052213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of pathological and biochemical outcomes after radical prostatectomy in Korean patients with serum PSA ranges.
    Lee HW; Jeon HG; Jeong BC; Seo SI; Jeon SS; Choi HY; Lee HM
    J Korean Med Sci; 2015 Mar; 30(3):317-22. PubMed ID: 25729256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence of perineural invasion on prostate biopsy specimen and survival after radical prostatectomy.
    DeLancey JO; Wood DP; He C; Montgomery JS; Weizer AZ; Miller DC; Jacobs BL; Montie JE; Hollenbeck BK; Skolarus TA
    Urology; 2013 Feb; 81(2):354-7. PubMed ID: 23374801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncologic outcomes at 10 years following robotic radical prostatectomy.
    Diaz M; Peabody JO; Kapoor V; Sammon J; Rogers CG; Stricker H; Lane Z; Gupta N; Bhandari M; Menon M
    Eur Urol; 2015 Jun; 67(6):1168-1176. PubMed ID: 24996687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathologic outcomes for low-risk prostate cancer after delayed radical prostatectomy in the United States.
    Weiner AB; Patel SG; Eggener SE
    Urol Oncol; 2015 Apr; 33(4):164.e11-7. PubMed ID: 25624093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathological Characteristics of Prostate Cancer in Men Aged < 50 Years Treated with Radical Prostatectomy: a Multi-Centre Study in Korea.
    Chung MS; Shim M; Cho JS; Bang W; Kim SI; Cho SY; Rha KH; Hong SJ; Koo KC; Lee KS; Chung BH; Lee SH
    J Korean Med Sci; 2019 Mar; 34(10):e78. PubMed ID: 30886549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radical prostatectomy and positive surgical margins: relationship with prostate cancer outcome.
    De La Roca RL; Da Cunha IW; Bezerra SM; Da Fonseca FP
    Int Braz J Urol; 2014; 40(3):306-15. PubMed ID: 25010296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immediate versus delayed radical prostatectomy: updated outcomes following active surveillance of prostate cancer.
    Filippou P; Welty CJ; Cowan JE; Perez N; Shinohara K; Carroll PR
    Eur Urol; 2015 Sep; 68(3):458-63. PubMed ID: 26138041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative characteristics of men with unfavorable high-Gleason prostate cancer at radical prostatectomy.
    Pierorazio PM; Lin BM; Mullins JK; Hyndman ME; Schaeffer EM; Han M; Partin AW; Pavlovich CP
    Urol Oncol; 2013 Jul; 31(5):589-94. PubMed ID: 21664838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term radical prostatectomy outcomes among participants from the European Randomized Study of Screening for Prostate Cancer (ERSPC) Rotterdam.
    Loeb S; Zhu X; Schroder FH; Roobol MJ
    BJU Int; 2012 Dec; 110(11):1678-83. PubMed ID: 22998182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aetiology and management of earlier vs later biochemical recurrence after retropubic radical prostatectomy.
    Llukani E; Lepor H
    BJU Int; 2017 Oct; 120(4):505-510. PubMed ID: 28220652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upgrading and upstaging of low-risk prostate cancer among Korean patients: a multicenter study.
    Hwang I; Lim D; Jeong YB; Park SC; Noh JH; Kwon DD; Kang TW
    Asian J Androl; 2015; 17(5):811-4. PubMed ID: 25578934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of robot-assisted and open retropubic radical prostatectomy for risk of biochemical progression in men with positive surgical margins.
    Shapiro EY; Scarberry K; Patel T; Bergman A; Ahn JJ; Sahi N; RoyChoudhury A; Deutch I; McKiernan JM; Benson MC; Badani KK
    J Endourol; 2014 Feb; 28(2):208-13. PubMed ID: 24044423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.